Abstract

Mannan-oligosaccharides (MOS) have been identified as feed additives that potentially affect gastrointestinal status in different animal species. The present study aimed to investigate the effect of supplemental MOS on production performance, immunological responses, and ileal bacterial communities in aged laying hens. A total of one-hundred-fifty 68 weeks-aged laying hens (Hy-Line W-36) were randomly allotted to the 6 replicates (5 hens per each) of 5 experimental diets. Dietary treatments consisted of 5 different levels of MOS (0, 0.5, 1, 1.5, and 2g/kg of diet). After a 7-d of adaptation, the main experimental period was commenced for 70-d subdivided into two 35-d periods (69–74 and 74–79 weeks of age). Results showed that dietary supplementation of MOS at the levels of 1 and 1.5g/kg increased (P<0.05) egg production percentage during the whole experimental period. As a result, the greatest egg mass was allotted to these experimental groups throughout the trial period. Supplementation of MOS at the levels of 1–2g/kg reduced (P<0.01) serum concentrations of triglycerides and low-density lipoproteins, and increased (P<0.01) serum high-density lipoproteins compared to the control hens. Dietary supplementation of MOS increased (P<0.05) antibody production titers against Newcastle and infectious bronchitis disease viruses. Moreover, inclusion of MOS into the diets increased digestibility coefficients of crude protein (P<0.01) and dry matter (P<0.05). Ileal population of Salmonella was greater (P<0.01) in control birds compared with other experimental groups. Supplemental MOS at the level of 1g/kg decreased (P<0.05) ileal enumerations of Escherichia coli and total bacteria. The present findings indicate that dietary MOS supplementation, particularly at the levels of 1 and 1.5g/kg, could increase production performance and feed conversion efficiency in aged laying hens. These improvements could be mainly attributed to the increased ileal nutrient digestibility and reduced pathogenic intestinal bacteria as the result of dietary supplementation of MOS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.